A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

NCT01710501 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C (CHC)

Interventions

DRUG: Grazoprevir
BIOLOGICAL: pegylated interferon alfa-2b
DRUG: Ribavirin
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC